These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6657734)

  • 1. [Drugs and the organism (IV). Prodrugs--a means of drug optimization].
    Pfeifer S
    Pharmazie; 1983 Oct; 38(10):663-6. PubMed ID: 6657734
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug targeting using conjugates: the importance of pharmaceutical chemistry.
    Byrn SR; Stowell JG
    J Drug Target; 1995; 3(4):239-41. PubMed ID: 8820996
    [No Abstract]   [Full Text] [Related]  

  • 3. Some aspects of pharmacokinetic and biotransformation differences in humans and mammal animals.
    Chodera A; Feller K
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):357-60. PubMed ID: 99374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs.
    Garrett ER
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):6-20. PubMed ID: 4924331
    [No Abstract]   [Full Text] [Related]  

  • 5. [Possibilities and problems of organ-selective active principles and drugs].
    Hamacher H
    Pharmazie; 1981 Jun; 36(6):391-9. PubMed ID: 7025022
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drugs and the organism. II. Bioavailability].
    Pflegel P; Pfeifer S
    Pharmazie; 1980; 34(5-6):337-59. PubMed ID: 6893363
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of binding kinetics in therapeutically useful drug action.
    Swinney DC
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):31-9. PubMed ID: 19152211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The fate of drug in the developing organism (author's transl)].
    Prokopczyk J
    Probl Med Wieku Rozwoj; 1977; 7():198-234. PubMed ID: 614569
    [No Abstract]   [Full Text] [Related]  

  • 9. [Drug administration and the nurse. Various pharmacokinetic aspects].
    van Wyk M
    Curationis; 1983 Jun; 6(2):47-9. PubMed ID: 6556962
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of renal excretory insufficiency on pharmacokinetics and dosage of drugs].
    Kokot F
    Przegl Lek; 1982; 39(7):453-67. PubMed ID: 7178517
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pro-drugs].
    MachoĊ„ Z
    Postepy Hig Med Dosw; 1979; 33(4):345-75. PubMed ID: 514925
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug dosage optimization taking into account human circadian rhythms].
    Kudrin AN; Davydova ON; Zatsepilova TA; Riazhenov VV
    Sov Med; 1985; (10):37-41. PubMed ID: 3909447
    [No Abstract]   [Full Text] [Related]  

  • 13. [Practical aspects of pharmacokinetics in renal failure].
    Orzechowska-Juzwenko K; Janicki AG
    Pol Tyg Lek; 1982 Oct; 37(39):1181-4. PubMed ID: 7163064
    [No Abstract]   [Full Text] [Related]  

  • 14. Prodrugs and site-specific drug delivery.
    Stella VJ; Himmelstein KJ
    J Med Chem; 1980 Dec; 23(12):1275-82. PubMed ID: 7005447
    [No Abstract]   [Full Text] [Related]  

  • 15. Nanosuspensions in drug delivery.
    Rabinow BE
    Nat Rev Drug Discov; 2004 Sep; 3(9):785-96. PubMed ID: 15340388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What are the mechanisms by which pro-drugs are activated in the body?
    Bundgaard H
    J Clin Hosp Pharm; 1983 Jun; 8(2):153-4. PubMed ID: 6875012
    [No Abstract]   [Full Text] [Related]  

  • 17. The principles of pharmacology.
    Vajda FJ
    Aust Fam Physician; 1980 Mar; 9(3):134-141. PubMed ID: 7369946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A commentary: methods and assumptions in the kinetic estimation of metabolite formation.
    Pang KS; Kwan KC
    Drug Metab Dispos; 1983; 11(2):79-84. PubMed ID: 6133727
    [No Abstract]   [Full Text] [Related]  

  • 19. Minimizing metabolic activation during pharmaceutical lead optimization: progress, knowledge gaps and future directions.
    Kumar S; Kassahun K; Tschirret-Guth RA; Mitra K; Baillie TA
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):43-52. PubMed ID: 18175266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of pharmaceutical profiling assays for optimization of drug-like properties.
    Di L; Kerns EH
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):495-504. PubMed ID: 16022186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.